AMRA Medical’s MRI data provide a unique opportunity for Pfizer’s GWAS
LINKÖPING, Sweden; February 14, 2022—One of the goals of AMRA’s collaboration with Pfizer and UK Biobank is to help identify and validate…
Read MoreMedical Research
LINKÖPING, Sweden; February 14, 2022—One of the goals of AMRA’s collaboration with Pfizer and UK Biobank is to help identify and validate…
Read MoreCorporate
Dear Friends, The AMRA Team is wishing you uplifted Happy Holidays filled with joy and warmth, and a prosperous Happy New Year!…
Read MoreCorporate
LINKÖPING, Sweden; December 21, 2021—AMRA Medical, a ground-breaking digital health company and global leader in body composition analysis offering medical device and…
Read MoreMedical Device
LINKÖPING, Sweden; December 7, 2021—AMRA Medical, a ground-breaking digital health company and global leader in body composition analysis, announced today that the…
Read MoreMedical Device
LINKÖPING, Sweden; December 2, 2021 — AMRA Medical, a ground-breaking digital health company and global leader in body composition analysis offering medical…
Read MoreMedical Research
LINKÖPING, Sweden; November 24, 2021 – AMRA Medical will introduce two high-precision magnetic resonance imaging (MRI) analysis services for assessing body composition…
Read More